Patent details

EP3880654 Title: 2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN

  • Data
  • Documents

Basic Information

Publication number:
EP3880654
PCT Application Number:
US2019062054
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP198184012
PCT Publication Number:
WO2020106642
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN
French Title of Invention:
COMPOSÉS DE 2-FORMYL-3-HYDROXYPHÉNYLOXYMÉTHYLE CAPABLES DE MODULER L'HÉMOGLOBINE
German Title of Invention:
2-FORMYL-3-HYDROXYPHENYLOXYMETHYLVERBINDUNGEN, DIE HÄMOGLOBIN MODULIEREN KÖNNEN
SPC Number:

Dates

Filing date:
18/11/2019
Grant date:
29/12/2021
EP Publication Date:
22/09/2021
PCT Publication Date:
28/05/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/12/2021
EP B1 Publication Date:
29/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/11/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/12/2021
 
 

Name:
Global Blood Therapeutics, Inc.
Address:
181 Oyster Point Blvd., South San Francisco, CA 94080, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/12/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
LI, Zhe
Address:
United States (US)

Priority

1

Priority Number:
201862769196 P
Priority Date:
19/11/2018
Priority Country:
United States (US)

2

Priority Number:
201962821314 P
Priority Date:
20/03/2019
Priority Country:
United States (US)

3

Priority Number:
201962848773 P
Priority Date:
16/05/2019
Priority Country:
United States (US)

4

Priority Number:
201962883313 P
Priority Date:
06/08/2019
Priority Country:
United States (US)

Classification

IPC classification:
C07D 207/08; C07D 211/22; C07D 265/30; C07D 279/12; C07D 401/06; C07D 401/10; C07D 403/06; C07D 413/06; C07D 417/06; A61P 7/06; A61K 31/40; A61K 31/4427; A61K 31/445; A61K 31/4523; A61K 31/497; A61K 31/5375; A61K 31/5377; A61K 31/54; A61K 31/541;

Publication

European Patent Bulletin

1

Issue number:
202152
Publication date:
29/12/2021
Description:
Grant (B1)

2

Issue number:
202204
Publication date:
26/01/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202207
Publication date:
16/02/2022
Description:
Inventor(s) changed

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/10/2024
Last Annual Fee Paid Number:
6
Last Annual Fee Paid Amount:
66 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)